Breaking AI & Tech News Analyzed

Conversations about mundane topics are often dreaded, but research suggests that people enjoy them more than they anticipate. A study involving 1,800 volunteers found that participants enjoyed chatting about dull subjects, such as the stock market or vegan diets, more than they expected. The findings indicate that by avoiding potentially dull exchanges, individuals may miss out on the mood boost and health benefits that come with connecting with others. Elizabeth Trinh, a PhD candidate in management and organisations at the University of Michigan, noted that people tend to underestimate how interesting and enjoyable conversations about boring topics can be. Trinh and her colleagues conducted a series of experiments to gauge how people responded to conversations on dull topics. Participants were asked to predict how much they would enjoy discussing topics they considered boring, and then engage in brief conversations about those topics. The results, published in the Journal of Personality and Social Psychology, showed that people consistently found the conversations more enjoyable than they expected. The surprise enjoyment arises because individuals base their expectations on static components, such as the topic and the other person, rather than dynamic components, like the conversation itself. Trinh suggests that people may benefit from lowering the bar for what makes a conversation worth having and reframing conversational goals. Instead of focusing on enjoyment, individuals could think about what they might learn from the conversation. Nicholas Epley, a professor of behavioural science at the University of Chicago, added that the fear of a boring conversation shouldn’t prevent people from starting one. “If a conversation is boring once you’re in it, you also have a surprising amount of power to make it better!”

While the two‑week pause in the US‑Israel campaign against Iran remains uncertain, one constant is clear: Donald Trump lacks a concrete plan, but Benjamin Netanyahu does. The war’s stated aim – to cripple Iran’s state capacity – is only a stepping stone toward a larger vision of a Greater Israel. For Israel’s right‑wing, the phrase often evokes a purely territorial ambition: enlarging the land Israel claims. History shows this expansionist drive has repeatedly displaced Palestinians, a process that has accelerated dramatically in recent years. Since the war began, Israel has flattened Gaza, killing tens of thousands and reducing the civilian‑inhabitable area to roughly 12 % of its pre‑war size. In the West Bank, a wave of settlement expansion and property destruction rivals the scale of the 1967 conflict. Beyond the occupied territories, Israel has seized parts of Syria and is forging a de‑facto occupation zone in southern Lebanon, with ministers from Religious Zionism, Jewish Power and Likud openly demanding Israeli sovereignty there. Finance minister Bezalel Smotrich even called for an expansion “to Damascus,” and Netanyahu has publicly expressed a deep personal connection to this territorial vision. However, Greater Israel is as much a geopolitical and strategic construct as a land‑grab. Netanyahu’s ambition extends beyond occupying borders; he seeks a regional dominion built on new alliances and hard‑power dependencies. After the October 7 attacks and the ensuing Gaza devastation, Israel’s prospects for Arab‑state normalization stalled. Faced with a choice between a conciliatory approach and a zero‑sum rejection of a Palestinian future, Netanyahu chose the latter, aiming to eliminate Iran as a regional counterweight – a move that inevitably required massive US military involvement. Former Israeli security analysts note that, from the perspective of Sunni Gulf states, a weakened Iran would elevate Israel to the role of “dominant regional power.” Achieving this, according to the article, also means softening the Gulf Cooperation Council (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, UAE) and making them dependent on Israel for security and energy routes. The spill‑over of Iranian drone and missile attacks on GCC infrastructure is portrayed not as an accident but as a calculated element of Israel’s strategy. When the US‑Israel coalition struck Iranian energy sites, Iran retaliated against the Gulf, disrupting global oil flows through the Strait of Hormuz. Netanyahu seized the moment to propose “alternative routes” – oil and gas pipelines that would bypass Hormuz and Bab‑al‑Mandab, ending at Israeli Mediterranean ports. In a meeting with Indian Prime Minister Narendra Modi, Netanyahu outlined a “hexagon of alliances” linking India, Arab nations, African states, Greece, Cyprus and other Asian partners, positioning Israel as the central hub. Recent IDF strategy papers echo this, suggesting Israel could achieve “operational control” far beyond its borders without permanent occupation, likening the Middle East to a “jungle” where Israel would become the “queen.” Netanyahu now describes Israel not merely as a “regional superpower” but, in some contexts, as a “global superpower.” He promises the hexagonal alliance will confront a “radical Shia axis” and an “emerging radical Sunni axis,” with Turkey singled out as the next strategic threat. Dismissal of the Greater Israel rhetoric as wartime hyperbole would be misleading. The article warns that a permanent war‑oriented mindset permeates Israel’s political elite, security establishment and media, posing a risk of overreach and regional blowback. Containing this expansive vision may become one of the most pressing post‑war challenges for the Middle East.

Recent CDC data reveal a dramatic 1,200% increase in kratom‑related poisonings across the United States over the last ten years, with the most pronounced surge recorded in 2025. Researchers link this rise to the growing presence of 7‑hydroxymitragynine (7‑OH), a synthetically produced compound that mimics kratom’s effects but carries opioid‑like risks. Walter Prozialeck, pharmacology professor at Midwestern University, said the trend was expected, noting that the synthetic alkaloid has entered the market through energy drinks and other products since 2024. Christopher McCurdy of the University of Florida warned that marketing 7‑OH as “enhanced kratom” blurs the line for consumers, turning poison‑control calls into a conflated metric for both natural and synthetic products. By contrast, natural kratom (Mitragyna speciosa)—a Southeast Asian plant used for centuries as a pain reliever—has demonstrated a relatively favorable safety profile in animal and human studies. A 2018 statement from then‑HHS Secretary Brett Giroir rejected the DEA’s push to schedule kratom as a Schedule I substance, citing insufficient evidence of harm. Despite the scientific distinction, several states have moved to implement or propose blanket bans on all kratom products, prompting concern from clinicians and patient advocates. A recent user survey indicated that about 50% of respondents rely on kratom for chronic pain, while roughly 40% use it during addiction recovery. Personal testimonies underscore the plant’s therapeutic role. Jeff Maslan, a 68‑year‑old Californian with severe osteoarthritis, credits kratom with easing opioid withdrawal after multiple surgeries. Similarly, “Steven,” a disabled California resident, describes how kratom eliminated unbearable oxycodone withdrawal symptoms without producing the euphoric “warm fuzzy” feeling typical of opioids. Researchers emphasize that 7‑OH carries genuine opioid hazards, including addiction, severe withdrawal, and respiratory depression that can lead to fatal overdose. In animal models, 7‑OH demonstrated the same respiratory‑depression risk as classic opioids, whereas kratom’s primary alkaloid did not. Prozialeck and colleagues explain that kratom’s pharmacology is more nuanced: it partially activates opioid receptors while also engaging adrenergic and serotonin pathways, resembling a hybrid of a weak opioid and an SNRI‑type antidepressant. This multimodal action likely accounts for its lower euphoric potential and the reported boost in energy among users. Nevertheless, experts caution that kratom is not without risk. Fatal poisonings often involve co‑ingestion of potent opioids such as fentanyl, suggesting that some users may cycle between kratom and stronger substances, raising overdose danger due to reduced opioid tolerance. Additionally, heavy‑metal contamination has been detected in certain kratom batches, though the source—soil, processing, or storage—remains unclear. Given these complexities, the consensus among scholars like Austin Zamarripa (Johns Hopkins) is that natural kratom should remain accessible, while concentrated 7‑OH products merit stricter regulation. “These products may offer meaningful benefits to some individuals, and those benefits could be lost if access is restricted too broadly,” Zamarripa said, urging a differentiated policy approach. As the debate unfolds, patients like Steven worry that a sweeping ban would ignore the nuanced safety profile of the plant. “There’s corn on the cob, there’s high‑fructose corn syrup, there’s whiskey— all derived from corn but fundamentally different,” he remarked, highlighting the need for targeted, evidence‑based regulation rather than a one‑size‑fits‑all prohibition.

‘Departures’ arrives in UK and Irish theatres on 17 April, offering a sharply observed portrait of a man navigating the aftermath of a breakup. The story centers on Benji, a thirty‑something who, after parting ways with his charismatic trainer Jake, plunges into a haze of parties, substance use and fleeting encounters in an attempt to dull the ache of lost love. The film tackles weighty subjects—body‑image insecurity, familial rejection and the pressures of toxic masculinity—yet it avoids sentimentality by leaning into a darkly comic tone and a poppy visual palette. Its elliptical editing stitches together present‑day self‑destruction with fragmented memories of Jake, creating a nonlinear rhythm that mirrors the disorienting experience of a broken heart. Ey​re‑Morgan not only co‑writes and co‑directs but also embodies Benji, delivering a performance that feels both self‑deprecating and raw. His on‑screen chemistry with David Tag’s Jake provides the emotional anchor of the film, allowing the audience to glimpse the genuine connection that fuels Benji’s subsequent turmoil. Despite its strengths, the movie leans heavily on voice‑over narration, which at times hampers momentum, especially during emotionally charged scenes. The tendency to verbalise feelings rather than let the cinematography speak can feel redundant, and the multiple flashbacks occasionally drift into over‑exposition. Overall, ‘Departures’ stands as a thoughtful exploration of love, identity and the search for authenticity, while also showcasing the burgeoning talent emerging from northern England’s film scene.

Scientists at London's Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have announced a new AI-driven approach to identify how patients with advanced bowel cancer will respond to bevacizumab, a drug recently introduced by the NHS. The method uses PhenMap, an AI tool that integrates complex data on the genetic makeup of tumors, allowing researchers to track patterns of how different patients react to the drug. This development aims to spare potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. In the UK alone, nearly 10,000 cases of advanced bowel cancer are identified every year, with young adults seeing a particular rise in diagnoses. Bowel cancer has the second-highest mortality rate of any cancer, behind only lung cancer. While survival rates can be as high as 98% when caught early, the five-year survival rate for advanced bowel cancer can be as low as 10%. The study tracked 117 European bowel cancer patients who had been treated with chemotherapy and bevacizumab. Researchers identified a group of patients who all had the same gene mutation and were at a high risk of having negative reactions. The scientists behind the tests now hope to expand the number of patient samples and see if the results can be used in treatments for other types of cancer. Anguraj Sadanandam, a professor in stratification and precision medicine at the ICR, said: “Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won’t benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.” Sadanandam added that while the findings were encouraging, the tool would need to be tested on a larger cohort to be validated. “In future, I hope this approach will lead to a test that can be used by clinicians, to ensure patients receive personalised care that has the highest chance of working against their cancer.”

Rising energy costs stemming from the Iran war are set to deliver a sharp blow to British living standards, with the Resolution Foundation estimating that the average working‑age household could lose about £480 in income this year. Before the conflict began, the think‑tank projected a modest 0.9% rise in household earnings. Market‑driven energy price spikes have now pushed that forecast into a -0.6% decline, effectively turning a gain into a loss. Oil and gas markets have reacted dramatically: Brent crude has surged back above $100 per barrel (£74), while analysts such as JPMorgan Chase expect prices to stay elevated through the current quarter, with Goldman Sachs revising its Brent outlook to an average of $90 per barrel in Q2. For the poorest fifth of households, the outlook is equally grim. Expected income growth has been trimmed from 2.8% to 1.2%, despite a long‑overdue real‑terms increase in benefits for some low‑income families. Families with three or more children stand out as a relative bright spot. The abolition of the two‑child limit is projected to generate a 7.7% income boost for this group, contrasting with zero growth for poorer families with fewer children. Energy bills are also poised to climb this summer, erasing the £117 average savings households enjoyed after the regulator lowered the energy price cap in April, according to Jonathan Marshall, the foundation’s principal economist. In response, the Resolution Foundation is urging the UK government to fast‑track a social tariff before winter, aiming to shield the most vulnerable households from the worst of the price shock. James Smith, chief economist at the foundation, warned that “while hopes for sustained peace persist, the path of this conflict remains uncertain and energy prices stay well above pre‑war levels, meaning many households face a decline in purchasing power this year.” He added that “de‑escalation is welcome, but the damage to household finances is already largely done; the government should act now to prepare a social tariff that reaches households falling through the cracks this winter.”

Australian sprint prodigy Gout Gout stunned the athletics community on Sunday at the national championships in Sydney, clocking a legal 19.67 seconds over 200 m. The performance not only smashed his own previous national record of 20.02 seconds but also made him the first Australian to dip below the coveted 20‑second barrier. Gout’s coach and mentor, Di Sheppard, summed up the achievement with a wry grin: “How long’s a piece of string?” – a nod to the seemingly limitless potential the teenager now displays. The run placed Gout ahead of his compatriot Aidan Murphy, who finished a close second, and sparked immediate comparisons with Jamaican legend Usain Bolt. While Bolt’s all‑time best stands at 19.19 seconds (set in 2009), Gout’s 19.67 at the age of 18 already eclipses the Jamaican great’s performance at the same age, according to his camp. Only one other under‑20 athlete has ever posted a faster time – Erriyon Knighton – whose 2022 effort remains unratified after a subsequent ban. James Templeton, the 18‑year‑old’s manager, said the result was “thrilling but not shocking”, recalling that Gout ran 19.84 seconds the previous year with a marginal wind assistance, a time the team always considered his realistic benchmark. Gout himself has been fixated on breaking the sub‑20 mark ever since an illegal run earlier in his career. “I wrote down 19.75 and kept telling myself I’d hit it,” he explained. “Then I hit 19.67 – gotta love it.” Despite the historic run, the teenager shows no intention of slowing down. “I’ve just turned 18, so I definitely think I can go faster,” he said. “It’s about building consistency and there’s no pressure – I’m the only one out there.” Looking ahead, Gout will compete in the under‑20 junior championships this week, opting to skip the 200 m in Queensland and focus on the 100 m. He will then travel overseas for a high‑profile showdown with Olympic champion Noah Lyles over 150 m at the Golden Spike meet in Ostrava, scheduled for June. Should Gout continue his upward trajectory, the athletics world may soon witness a new challenger to Bolt’s long‑standing age‑group record, reshaping expectations for the next generation of sprint talent.

Scotland staged a late comeback to beat Wales 27‑22 in what was hailed as the best match of the opening weekend of the Women’s Six Nations, played at Cardiff’s Principality Stadium. The game attracted 10,569 spectators, the highest ever attendance for a Wales‑Scotland women’s clash on Welsh soil, though the venue’s 74,500‑seat capacity meant the atmosphere fell short of the stadium’s potential. Wales, led by head coach Sean Lynn, fought back from a 24‑12 halftime hole, narrowing the gap to five points in the closing minutes. Despite a valiant effort from their own try line, a mishandled line‑out in the dying seconds denied them a first Six Nations win since their 22‑20 victory over Italy in 2024. Scotland’s triumph was especially significant for new head coach Sione Fukofuka, who secured his inaugural win since taking the reins in December. Fly‑half Helen Nelson, named player of the match, praised the team’s defensive resilience and the blend of experienced and emerging talent. The match formed part of the Welsh Rugby Union’s strategy to showcase the women’s game in the national stadium, with plans to host at least one fixture there each season, hoping larger crowds will follow. Across the tournament, England set a new attendance benchmark with 77,120 fans at Twickenham for their 33‑12 win over Ireland, while upcoming fixtures promise further milestones: Scotland will play a standalone game at Murrayfield before heading to Dublin, and France, after a strong second‑half display against Italy, now sit atop the table on points difference. Looking ahead, Wales will face France at Cardiff Arms Park, where two of the three stands are already sold out, as the team aims to build on the “fight and character” displayed in Saturday’s encounter.

Polls have closed in Benin, with Finance Minister Romuald Wadagni expected to emerge victorious in the presidential election. Wadagni received the endorsement of former President Patrice Talon, who is stepping down after two five-year terms.Nearly eight million voters were eligible to cast ballots on Sunday to choose a successor to Talon. Wadagni, 49, faces a crucial factor in voter turnout after a lackluster campaign affected by voter apathy.In Benin’s largest city, Cotonou, vote counting began late on Sunday afternoon, with provisional results expected on Tuesday. Wadagni is being challenged by Paul Hounkpe, an opposition figure whose campaign has needed help from majority lawmakers to gain parliamentary endorsements.Under Talon, Benin has experienced rapid growth, with gross domestic product (GDP) doubling during his decade in power and numerous infrastructure projects completed. However, a wealth gap remains, and the winner of the vote will also face challenges with insecurity, particularly in the north of the country.The north of Benin has increasingly experienced violence from armed fighters from the Jama’at Nusrat al-Islam wal-Muslimin (JNIM), an al-Qaeda affiliate that has spilled over from the Sahel region.